Nucleo C.M.P. Forte 30 capsules — Made in Spain — Free Delivery

Pharmacodynamics. Nucleo C.M.P. Forte  contains nucleotides: cytidine monophosphate (cmp), uridine triphosphate (UTP), which are widely used to treat diseases of the central nervous system.

From a biochemical point of view, the action of these components is as follows.

CMP takes part in the synthesis of a complex of lipids that form the neuronal membrane, mainly sphingomyelin, the main component of the myelin sheath. CMP is also a precursor of nucleic acids (DNA and RNA), which, in turn, are the main elements of cellular metabolism (for example, in protein synthesis).

UTP acts as a coenzyme in the synthesis of glycolipids, neuronal structures and myelin sheath, complementing the action of CMP. In addition, UTP acts as an energy source during muscle contraction.

CMP and UTP are involved in the synthesis of phospholipids and glycolipids, which mainly make up the myelin sheath and other nerve structures. This leads to intense metabolic activity that promotes the process of regeneration of the myelin sheath, regulating demyelination in peripheral nerve injuries. Thus, the combination of the action of CMP and UTP contributes to the regeneration of the myelin sheath, the correct conduction of nervous excitation and the restoration of muscle trophism.

Pharmacokinetics. Nucleo C.M.F. Forte contains physiological products. Classical pharmacokinetic studies cannot be carried out due to the difficulty of quantifying exogenous and endogenous components. It is also impossible to conduct an analysis using a radioactively labeled product due to the high radiological burden.

Neuropathies of osteoarticular (sciatica, sciatica), metabolic (alcoholic, diabetic polyneuropathy), infectious origin (shingles, Bell's palsy).

Neuropathy of the facial, trigeminal nerve, intercostal neuralgia, lumbago.

Nucleo c.m.f. forte capsules are taken orally.

Adults: 1-2 capsules 2 times a day; children over the age of 5 years: 1 capsule 2 times a day.

Capsules Nucleo C.M.F. Forte can be taken before or after meals.

The recommended duration of treatment is at least 10 days. If necessary, the capsules can be extended for 20 days.

Nucleo C.M.F. Forte is a lyophilized powder for the preparation of a solution for injections - for intramuscular injection. Before administration, the solvent must be added to the vial with the lyophilized powder.

Adults, including elderly patients, and adolescents over the age of 14: 1 injection of Nucleo C.M.F. Forte is administered 1 time per day.

Children aged 2-14 years are recommended to administer 1 injection of Nucleo C.M.F. Forte every 2 days.

The recommended course of treatment is 3 or 6 days. Further treatment is continued using Nucleo C.M.F. Forte capsules.

Known allergic reactions to individual components of the preparation.

Not described. in persons with hypersensitivity, allergic reactions are possible. in the event of an adverse reaction due to the use of the preparation, a doctor's consultation is necessary.

Use during pregnancy and lactation. the use of the preparation during pregnancy and lactation is possible if, in the opinion of the doctor, the expected positive effect for the mother outweighs the potential risk to the fetus / child.

Children. The preparation is used in children over the age of 2 years.

The ability to influence the reaction rate when driving vehicles or working with other mechanisms. Nucleo C.M.F. Forte does not affect the ability to drive vehicles and work with complex mechanisms.

Interactions

Not installed.

Given the low toxicity of the preparation, an overdose is unlikely even if the therapeutic dose is accidentally exceeded.

At a temperature not higher than 30 °C.